The Clorox Company $CLX Stake Lifted by Empirical Finance LLC

Empirical Finance LLC lifted its stake in shares of The Clorox Company (NYSE:CLX) by 162.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,217 shares of the company’s stock after acquiring an additional 6,948 shares during the quarter. Empirical Finance LLC’s holdings in Clorox were worth $1,071,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Haverford Trust Co boosted its stake in Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares in the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of Clorox by 28.2% in the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after buying an additional 100 shares during the period. Kestra Private Wealth Services LLC lifted its holdings in shares of Clorox by 1.8% in the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after buying an additional 104 shares during the period. Johnson Financial Group Inc. boosted its stake in Clorox by 3.1% during the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after buying an additional 109 shares in the last quarter. Finally, State of Wyoming boosted its stake in Clorox by 4.7% during the second quarter. State of Wyoming now owns 2,540 shares of the company’s stock valued at $305,000 after buying an additional 113 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 2.2%

NYSE:CLX opened at $89.61 on Thursday. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $128.90. The firm has a market capitalization of $10.84 billion, a price-to-earnings ratio of 18.59, a price-to-earnings-growth ratio of 2.87 and a beta of 0.56. The stock has a fifty day simple moving average of $99.61 and a 200 day simple moving average of $100.89.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the previous year, the company earned $2.87 EPS. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Sell-side analysts forecast that The Clorox Company will post 5.8 earnings per share for the current year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 5.6%. This is an increase from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date of this dividend was Wednesday, August 12th. Clorox’s payout ratio is 103.73%.

Wall Street Analyst Weigh In

CLX has been the topic of several research reports. BNP Paribas Exane dropped their price target on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a research report on Monday, July 20th. Citigroup lifted their price objective on shares of Clorox from $97.00 to $100.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Wall Street Zen downgraded shares of Clorox from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. UBS Group boosted their target price on shares of Clorox from $100.00 to $105.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. Twelve analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $102.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.